Earnings Feed
Start Free
|4May 17, 2:40 PM ET

Cardiogenesis Corp /CA 4

4 · Cardiogenesis Corp /CA · Filed May 17, 2011

Insider Transaction Report

Form 4
Period: 2011-05-17
Cardiogenesis Corp /CACGCP.PK
LANIGAN RICHARD P
President
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−14,583→ 0 total
    Exercise: $0.91Exp: 2012-05-31→ Common Stock (14,583 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.16/sh−150,000$23,550→ 0 total
    Exercise: $0.30Exp: 2017-01-03→ Common Stock (150,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−83,333→ 0 total
    Exercise: $0.70Exp: 2013-06-24→ Common Stock (83,333 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−50,000→ 0 total
    Exercise: $1.03Exp: 2014-02-26→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−100,000→ 0 total
    Exercise: $0.50Exp: 2016-03-21→ Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.14/sh−58,802$8,056→ 0 total
    Exercise: $0.32Exp: 2013-01-07→ Common Stock (58,802 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−16,667→ 0 total
    Exercise: $0.70Exp: 2013-06-24→ Common Stock (16,667 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−75,000→ 0 total
    Exercise: $0.54Exp: 2015-01-14→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−13,890→ 0 total
    Exercise: $1.01Exp: 2011-08-02→ Common Stock (13,890 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−22,917→ 0 total
    Exercise: $0.91Exp: 2012-05-31→ Common Stock (22,917 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.14/sh−74,332$10,183→ 0 total
    Exercise: $0.32Exp: 2013-01-07→ Common Stock (74,332 underlying)
  • Disposition to Issuer

    Common Stock

    2011-05-17−231,895→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−11,110→ 0 total
    Exercise: $1.01Exp: 2011-08-02→ Common Stock (11,110 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.33/sh−250,000$81,750→ 0 total
    Exercise: $0.13Exp: 2019-02-23→ Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated April 14, 2011, by and among CryoLife, Inc., CL Falcon, Inc., and Cardiogenesis Corporation in exchange for cash consideration equal to $0.457 per share on the effective date of the merger (the "Merger"). This transaction is exempt under Rule 16b-3(e).
  • [F2]Option cancelled pursuant to the Merger in exchange for cash consideration equal to the difference between $0.457 and the exercise price of the Option multiplied by the number of Options canceled. This transaction is exempt under Rule 16b-3(e).

Documents

1 file
  • 4
    c17441_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION